Baton Pass at City of Hope Los Angeles
Join the Campaign at Facebook.Com/TheBatonPass
DUARTE, Calif. — Bone marrow transplants offer a second chance for people with life-threatening blood cancers and other hematologic malignancies. But many recipients, though overwhelmed with curiosity and the need to express their gratitude, can only dream of meeting the strangers who saved their lives. City of Hope is about to make that dream come true for two patients.
At City of Hope's annual Bone Marrow Transplantation Reunion on May 9, two grateful patients will meet the strangers, each hailing from different countries, who gave them back their futures.
"She's a world away, and we've never met, but we're – in a way – 'genetic twins,'" said George Winston, the impressionistic, genre-defying musician with more than 20 instrumental albums under his belt. Winston received a lifesaving transplant from a young German woman two years ago, and can't wait to get to know her. "It's amazing how they can locate a donor. I can't wait to meet her and just thank her from the bottom of my heart."
The meetings are the public focal point of City of Hope's annual Celebration of Life. Other meetings, and reunions, will take place throughout the event, attended by more than 6,500 bone marrow, stem cell and cord blood transplant recipients, their families and donors. All will celebrate second chances, scientific breakthroughs and transplant anniversaries.
And, in a first at City of Hope, a baton pass to support Stand Up to Cancer. The baton pass is a campaign to support Stand Up To Cancer's cancer research efforts. For every pass of the baton, Siemens, which supplies the healthcare industry with imaging and diagnostic technology, will donate $1 to Stand Up to Cancer, up to $1 million. The baton will be passed to City of Hope staff, patients and be passed through the crowd of reunion participants as they convene for a massive group photo.
About City of Hope
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on facebook, twitter, youtube or flickr.
"The Baton Pass™" broadcast quality footage from events across the country available: http://inr.synapticdigital.com/siemens/standuptocancer/
Siemens Corporation is a U.S. subsidiary of Siemens AG, a global powerhouse in electronics and electrical engineering, operating in the industry, energy, healthcare, and infrastructure & cities sectors. Siemens in the USA employs approximately 60,000 people throughout all 50 states and Puerto Rico. The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, healthcare information technology and hearing aids. Siemens has long believed that imaging technology plays a key role in advancing cancer research. We have seen firsthand the power of an early and accurate diagnosis. Our diagnostic technologies have made it possible to detect cancer in some of its earliest and most treatable stages, sometimes before a patient even experiences symptoms.
About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry's resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about progress being made in the fight against the disease. As SU2C's scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, Ph.D., conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.